Quick Answer
UNITED THERAPEUTICS Corp reported Total Assets of $7.88 billion for fiscal year 2025.
UNITED THERAPEUTICS Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.88B | +7.0% |
| 2024 | $7.36B | +2.7% |
| 2023 | $7.17B | +18.6% |
| 2022 | $6.04B | +16.9% |
| 2021 | $5.17B | +12.0% |
| 2020 | $4.62B | +17.9% |
| 2019 | $3.91B | +15.1% |
| 2018 | $3.40B | +18.1% |
| 2017 | $2.88B | +23.8% |
| 2016 | $2.33B | +6.5% |
| 2015 | $2.18B | +15.9% |
| 2014 | $1.88B | -9.7% |
| 2013 | $2.09B | +28.3% |
| 2012 | $1.63B | +7.1% |
| 2011 | $1.52B | +6.0% |
| 2010 | $1.43B | +36.1% |
| 2009 | $1.05B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.35B | +3.2% | -7.0% |
| June 30, 2025 | $7.91B | +17.6% | +2.1% |
| March 31, 2025 | $7.74B | +19.2% | +5.2% |
| December 31, 2024 | $7.36B | +2.7% | +3.4% |
| September 30, 2024 | $7.12B | +1.4% | +5.9% |
| June 30, 2024 | $6.72B | +0.6% | +3.5% |
| March 31, 2024 | $6.50B | +2.4% | -9.4% |
| December 31, 2023 | $7.17B | +18.6% | +2.0% |
- UNITED THERAPEUTICS Corp showed an increase of +7.0% in Total Assets compared to the prior fiscal year.
- Over the 2009–2025 period, UNITED THERAPEUTICS Corp’s total assets has grown by 649.4% (from $1.05 billion to $7.88 billion).
- The most recent figure is from UNITED THERAPEUTICS Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: